For CT coronary angiography, should I use sublingual glyceryl trinitrate (GTN) spray or oral GTN tablets, and what are the recommended dosing and timing?

Glyceryl Trinitrate Spray vs Tablets for CT Coronary Angiography

For CT coronary angiography, use sublingual nitroglycerin spray (0.8 mg or 2 puffs of 0.4 mg) rather than tablets (0.5 mg), as spray produces superior coronary vasodilation, particularly in peripheral vessels, without compromising image quality or FFRCT values.

Formulation and Dosing

Spray Administration (Preferred)

• Dose: 0.8 mg total (2 puffs of 0.4 mg each) of isosorbide dinitrate (ISDN) spray 1
• Timing: Administer immediately before the scan 2
• Advantages:
  • Produces significantly larger coronary diameters across all segments except ramus intermedius and left posterior descending artery 1
  • Increases coronary luminal volume by approximately 8% compared to lower doses 3
  • More effective in peripheral and branch vessels, not just main coronary arteries 1
  • Maintains efficacy even in elderly patients 1

Tablet Administration (Alternative)

• Dose: 0.3-0.4 mg sublingual nitroglycerin 4, 5
• Timing: Dissolve under tongue or in buccal pouch immediately before scan
• Limitations: Produces 11-21% smaller vessel diameters in proximal segments compared to spray 6, 7

Evidence Comparison

The most recent high-quality study 1 (2021, European Radiology) directly compared spray versus tablet administration in 2,024 patients and found:

• All coronary segments except RI and L-PDA were significantly larger with spray (p<0.001)
• Both peripheral/branch vessels AND central/main coronary arteries showed superior dilation with spray
• In a subgroup of 93 patients who underwent CCTA twice with both methods, spray consistently produced larger diameters

A 2023 study 6 found no systematic superiority of either method, but this used lower spray doses (0.8 mg) versus tablets (0.5 mg) and only examined proximal vessels, missing the peripheral vessel advantage demonstrated in other studies.

Coronary Vasodilation Effects

Expected Diameter Increases

With sublingual nitroglycerin (spray or tablet), expect:

• Major segments: 11-12% increase in diameter 8, 7
• Minor/peripheral segments: 17-22% increase in diameter 8
• Specific vessels (with 1.2 mg spray): LMA +12%, LAD +17%, LCX +19%, RCA +21% 7

The magnitude of vasodilation inversely correlates with baseline diameter (r=-0.48, p<0.001) 8, meaning smaller vessels benefit more.

Practical Protocol

Patient Preparation

1. Screen for contraindications 9, 4:

   • Systolic BP <90 mmHg or ≥30 mmHg below baseline
   • Heart rate <50 or >100 bpm (in absence of heart failure)
   • Recent phosphodiesterase-5 inhibitor use (sildenafil within 24h, tadalafil within 48h) 5
   • Severe aortic stenosis or hypertrophic obstructive cardiomyopathy 10
   • Right ventricular infarction 11

2. Heart rate control: Target <65 bpm with beta-blockers before GTN administration 10

3. Patient positioning: Have patient sit during administration to prevent orthostatic hypotension 5

Administration Technique

• Spray: 2 puffs of 0.4 mg ISDN spray (0.8 mg total) immediately before scanning
• Tablet alternative: 0.3-0.4 mg sublingual nitroglycerin if spray unavailable
• Wait 3-5 minutes after administration before initiating scan to allow maximal vasodilation

Impact on Image Quality and Analysis

FFRCT Considerations

A 2019 study 3 examining different NTG doses (0.4 mg vs 0.8 mg) found:

• Higher dose (0.8 mg) significantly increased coronary volume (2639 vs 2845 mm³, p=0.009)
• No change in FFRCT values despite increased volume
• Volume-to-mass ratio unchanged (p=0.20)

This indicates that while higher doses improve vessel visualization, they don't artificially alter functional assessment.

Image Quality

• No significant difference in overall image quality scores between spray and tablet 6
• Signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) remain comparable 12
• Increased vessel diameter improves visualization of perforators and small branches 12

Common Pitfalls

1. Inadequate dosing: Using only 0.4 mg spray (1 puff) instead of 0.8 mg (2 puffs) reduces vasodilation benefit
2. Timing errors: Scanning too quickly after administration (<3 minutes) or waiting too long (>10 minutes)
3. Missing contraindications: Failing to screen for recent PDE-5 inhibitor use is potentially harmful 5
4. Patient position: Allowing patient to stand immediately after GTN increases fall risk from orthostatic hypotension 5
5. Dry mouth interference: Tricyclic antidepressants and anticholinergics reduce saliva, impairing tablet dissolution 5, 13—spray bypasses this issue

Bottom Line

Choose spray over tablets for CT coronary angiography. Use 0.8 mg ISDN spray (2 puffs of 0.4 mg) immediately before scanning after confirming no contraindications and achieving heart rate <65 bpm. This produces superior coronary vasodilation, particularly in peripheral vessels, without compromising functional assessment or image quality. The choice between formulations can otherwise be guided by practical and economic considerations 6, but spray offers measurable advantages in vessel visualization 1.